Evolent Health, Inc. (NYSE:EVH) went down by -4.04% from its latest closing price when compared to the 1-year high value of $29.05 and move down -308.01%, while EVH stocks collected +22.34% of gains with the last five trading sessions.
Evolent Health, Inc. (NYSE:EVH) Worth an Investment?
Evolent Health, Inc. (NYSE: EVH) The 36 Months beta value for EVH stocks is at 1.04, while 12 of the analysts out of 14 who provided ratings for Evolent Health, Inc. stocks as a “buy” while 1 as overweight, 1 rated it as hold and 0 as sell. The average price we get from analysts is $17.08 which is $9.96 above current price. EVH currently has a short float of 13,783,222.82% and public float of 81.97 with average trading volume of 1.66M shares.
EVH Market Performance
EVH stocks went up by 22.34% for the week, with the monthly drop of -4.30% and a quarterly performance of -49.58%, while its annual performance rate touched -67.56%. The simple moving average for the period of the last 20 days is 5.40% for EVH stocks with the simple moving average of -51.60% for the last 200 days.
Analysts’ Opinion on Evolent Health, Inc. (NYSE:EVH)
Many brokerage firms have already submitted their reports for EVH stocks, with Leerink Partners repeating the rating for EVH shares by setting it to “Outperform”. The predicted price for EVH socks in the upcoming period according to Leerink Partners is $35 based on the research report published on October 5, 2018.
Piper Jaffray, on the other hand, stated in their research note that they expect to see EVH stock at the price of $30. The rating they have provided for EVH stocks is “Overweight” according to the report published on June 4, 2018.
JP Morgan gave “Neutral” rating to EVH stocks, setting the target price at $17 in the report published on April 24, 2018.
EVH Stocks -6.66% Far from 50 Day Moving Average
After a stumble in the market that brought EVH to its low price for the period of the last 52 weeks, Evolent Health, Inc. was unable to take a rebound, for now settling with -75.49% of loss for the given period.
The stock volatility was left at 8.63%, however, within the period of a single month, the volatility rate increased by 16.44%, while the shares sank at the distance of -4.56% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by -33.02% lower at the present time.
In the course of the last 5 trading sessions, EVH went up by +22.34%, which changed the moving average for the period of 200 days to the total of -67.20% of losses for the stock in comparison to the 20-day moving average settled at $6.74. In addition, Evolent Health, Inc. saw -64.31% in overturn over the period of a single year with a tendency to cut further losses.
EVH Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Evolent Health, Inc. (EVH), starting from D’Amato Michael, who bought 15,000 shares at the price of $7.03 back on Aug 09. After this action, Rushing now owns 67,368 shares of Evolent Health, Inc., valued at $105,450 with the latest closing price.
Weinberg Jonathan, the General Counsel of Evolent Health, Inc., sold 15,000 shares at the value of $27.12 during a trade that took place back on Sep 13, which means that Weinberg Jonathan is holding 26,775 shares at the value of $406,800 based on the most recent closing price.
EVH Stock Fundamentals
The current profitability levels are settled at +3.78 for the present operating margin and +40.62 for gross margin. The net margin for Evolent Health, Inc. stands at -8.40. Total capital return value is set at 1.84, while invested capital returns managed to touch -4.22. Equity return holds the value -4.90%, with -3.50% for asset returns.
Based on Evolent Health, Inc. (EVH), the company’s capital structure generated 19.32 points for debt to equity in total, while total debt to capital is set at the value of 16.20. Total debt to assets is settled at the value of 12.83 with long-term debt to equity ratio rests at 19.32 and long-term debt to capital is 16.20.
EBITDA value lies at -19.44 M with total debt to EBITDA carrying the value of 3.24. The value for Enterprise to Sales is 0.58 with debt to enterprise value settled at 0.15. The receivables turnover for Evolent Health, Inc. is 8.29 with the total asset turnover at the value of 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.81.